These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Phosphorylated S6 kinase and S6 ribosomal protein are diagnostic markers of antibody-mediated rejection in heart allografts. Li F; Wei J; Valenzuela NM; Lai C; Zhang Q; Gjertson D; Fishbein MC; Kobashigawa JA; Deng M; Reed EF J Heart Lung Transplant; 2015 Apr; 34(4):580-587. PubMed ID: 25511749 [TBL] [Abstract][Full Text] [Related]
28. Evaluation of CXCL9 and CXCL10 as circulating biomarkers of human cardiac allograft rejection. Karason K; Jernås M; Hägg DA; Svensson PA BMC Cardiovasc Disord; 2006 Jun; 6():29. PubMed ID: 16780603 [TBL] [Abstract][Full Text] [Related]
29. Endomyocardial biopsy for monitoring heart transplant patients: 11-years-experience at a german heart center. Strecker T; Rösch J; Weyand M; Agaimy A Int J Clin Exp Pathol; 2013; 6(1):55-65. PubMed ID: 23236543 [TBL] [Abstract][Full Text] [Related]
30. Myeloperoxidase as serum marker for detection of CMV infections and rejections in patients after liver or heart transplantation. Zelzer S; Stiegler P; Kapitan M; Schaffellner S; Schweiger M; Stettin M; Stojakovic T; Truschnig-Wilders M; Tscheliessnigg KH; Khoschsorur G Transpl Immunol; 2009 Jan; 20(3):121-6. PubMed ID: 18930821 [TBL] [Abstract][Full Text] [Related]
31. An ectopically expressed serum miRNA signature is prognostic, diagnostic, and biologically related to liver allograft rejection. Shaked A; Chang BL; Barnes MR; Sayre P; Li YR; Asare S; DesMarais M; Holmes MV; Guettouche T; Keating BJ Hepatology; 2017 Jan; 65(1):269-280. PubMed ID: 27533743 [TBL] [Abstract][Full Text] [Related]
32. Predictive role of pretransplant serum CXCL10 for cardiac acute rejection. Crescioli C; Buonamano A; Scolletta S; Sottili M; Francalanci M; Giomarelli P; Biagioli B; Lisi G; Pradella F; Serio M; Romagnani P; Maccherini M Transplantation; 2009 Jan; 87(2):249-55. PubMed ID: 19155980 [TBL] [Abstract][Full Text] [Related]
33. Elevated serum concentrations of cardiac troponin T in acute allograft rejection after human heart transplantation. Dengler TJ; Zimmermann R; Braun K; Müller-Bardorff M; Zehelein J; Sack FU; Schnabel PA; Kübler W; Katus HA J Am Coll Cardiol; 1998 Aug; 32(2):405-12. PubMed ID: 9708468 [TBL] [Abstract][Full Text] [Related]
34. Exosome-derived galectin-9 may be a novel predictor of rejection and prognosis after liver transplantation. Zhang AB; Peng YF; Jia JJ; Nie Y; Zhang SY; Xie HY; Zhou L; Zheng SS J Zhejiang Univ Sci B; 2019 Jul; 20(7):605-612. PubMed ID: 31168974 [TBL] [Abstract][Full Text] [Related]
35. Outcome of antibody-mediated rejection compared to acute cellular rejection after pediatric heart transplantation. Vaughn GR; Jorgensen NW; Law YM; Albers EL; Hong BJ; Friedland-Little JM; Kemna MS Pediatr Transplant; 2018 Feb; 22(1):. PubMed ID: 29222866 [TBL] [Abstract][Full Text] [Related]
36. SERCA2a: A potential non-invasive biomarker of cardiac allograft rejection. Tarazón E; Ortega A; Gil-Cayuela C; Sánchez-Lacuesta E; Marín P; Lago F; González-Juanatey JR; Martínez-Dolz L; Portolés M; Rivera M; Roselló-Lletí E J Heart Lung Transplant; 2017 Dec; 36(12):1322-1328. PubMed ID: 28750934 [TBL] [Abstract][Full Text] [Related]